The store will not work correctly when cookies are disabled.
N-[4-(5-Chloro-1H-indol-3-yl)-thiazol-2-yl]-guanidine: hydrochloride
ID: ALA2448019
PubChem CID: 73351177
Max Phase: Preclinical
Molecular Formula: C12H11Cl2N5S
Molecular Weight: 291.77
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: Cl.N=C(N)Nc1nc(-c2c[nH]c3ccc(Cl)cc23)cs1
Standard InChI: InChI=1S/C12H10ClN5S.ClH/c13-6-1-2-9-7(3-6)8(4-16-9)10-5-19-12(17-10)18-11(14)15;/h1-5,16H,(H4,14,15,17,18);1H
Standard InChI Key: DNGODGYWKPMHSC-UHFFFAOYSA-N
Molfile:
RDKit 2D
20 21 0 0 0 0 0 0 0 0999 V2000
8.6250 -13.5268 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
8.0781 -11.5007 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.4155 -12.0020 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.1595 -12.4456 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.6262 -11.7600 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.3297 -12.4514 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
8.9020 -11.5180 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.8361 -10.7228 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.5103 -10.2388 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.6549 -13.1024 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
4.5000 -12.4514 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.4328 -12.8317 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.1671 -10.7401 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.4437 -12.1402 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.9796 -10.5845 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.0852 -11.7254 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.0794 -13.1716 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
10.2503 -11.9847 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.5154 -11.2010 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.7920 -12.6069 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
3 2 1 0
4 5 2 0
5 3 1 0
6 4 1 0
7 2 1 0
8 2 2 0
9 8 1 0
10 12 1 0
11 6 1 0
12 3 2 0
13 7 2 0
14 7 1 0
15 13 1 0
16 11 2 0
17 11 1 0
18 14 2 0
19 18 1 0
20 18 1 0
9 13 1 0
10 4 1 0
19 15 2 0
M END
Associated Targets(Human)
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 291.77 | Molecular Weight (Monoisotopic): 291.0345 | AlogP: 3.25 | #Rotatable Bonds: 2 |
Polar Surface Area: 90.58 | Molecular Species: NEUTRAL | HBA: 3 | HBD: 4 |
#RO5 Violations: ┄ | HBA (Lipinski): 5 | HBD (Lipinski): 5 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 6.73 | CX LogP: 3.03 | CX LogD: 2.94 |
Aromatic Rings: 3 | Heavy Atoms: 19 | QED Weighted: 0.43 | Np Likeness Score: -1.52 |
References
1. LaMattina JL, McCarthy PA, Reiter LA, Holt WF, Yeh LA.. (1990) Antiulcer agents. 4-substituted 2-guanidinothiazoles: reversible, competitive, and selective inhibitors of gastric H+,K(+)-ATPase., 33 (2): [PMID:2153817] [10.1021/jm00164a012] |